Thiago Carvalho, PH.D., is currently a pharmaceutical scientist in drug product science and technology at Bristol-Myers-Squibb.
Jeff Hemenway, Ph.D., is currently a pharmaceutical scientist in formulation and process development at Gilead Sciences.
The transition from academia to industry is extremely challenging for pharmaceutical scientists. The changes involved in this transition are huge, and there is always a great deal of uncertainty surrounding the entire process. This process and the time leading up to it can be very stressful and loaded with pitfalls.
View original post 430 more words